Angiostatin抑制转移性肿瘤血液灌注和间质液输运的数值模拟

数值研究抗血管生成因子Angiostatin对转移性肿瘤微循环内血液灌注和间质液输运的抑制效应.肿瘤微血管网生成数学模型包括angiostatin的抑制效应、促血管生成因子的趋化效应和内皮细胞自身的扩散效应,血液灌注、间质液输运和跨壁流体交换分别采用Poiseuille、Darcy和Starling定律来描述.结果表明:angiostatin能抑制转移性肿瘤内外微血管网的生长速率、毛细血管芽的分叉、融合与增殖;进一步angiostatin可改善转移性肿瘤微环境内血液灌注和间质液输运的特性,从而增加微血管内外流体对流和物质交换的能力,降低肿瘤内药物输运困难,结果与实验相符,可为临床抗血管生成治疗肿瘤提供有益信息.     

简易型微流控芯片捕获循环肿瘤细胞的研究

本研究以循环肿瘤细胞(乳腺肿瘤细胞)为研究对象,以聚二甲基硅氧烷(PDMS)、双面粘性薄膜(DSA)、玻片为原材料,采用激光雕刻技术制作微流控芯片,结合巯基-马来酰亚胺基团硅烷化偶联法和免疫荧光技术进行芯片内捕获检测实验,并使用外周血肿瘤细胞来验证此微流控芯片的实用性,使用具有高速摄像功能的荧光显微镜进行镜下观察及拍摄. 成功构建了一种简易型微流控芯片系统,利用此系统可实现对乳腺肿瘤细胞(92±3)%的捕获率,对外周血肿瘤细胞(88±3)%的捕获率,而且芯片的制作工艺简单,对实验仪器要求低,1 min内即可制作完成,简化了制作过程,弥补了传统光刻工艺复杂繁琐的不足,为临床检测疾病的发生与发展提供了新的研究方向.     

壳聚糖基多功能纳米药物载体的体外研究

制备了一种壳聚糖基多功能纳米药物载体系统, 并探讨了其体外释药性质. 合成了甲氨蝶呤-壳聚糖偶联物(MTX-CS), 甲氨喋呤(MTX)的取代度为6.3%; MTX-CS具有两亲性, 在水性介质中能自组装形成纳米粒子, 平均粒径为(269.5±18.3) nm, zeta电位为(25.7±0.9) mV. MTX-CS纳米粒子能有效包载抗血管生成药Combretastatin A-4(CA-4), 当药物/载体材料投料比为1∶4 时, 载药量为15.7%, 包封率为62.8%. 体外释放实验结果显示, CA-4释放较快, MTX释放缓慢, 有利于发挥2种药物的协同抗肿瘤作用.     

p73变异体研究现状及其在肿瘤放疗中的应用前景

p73基因是p53抑癌基因家族的新成员。 p73有两组蛋白异构体: TAp73和DNp73。 TAp73具有诱导细胞周期停滞和细胞凋亡的能力, 而DNp73却有与之相反的能力, 具有肿瘤促进作用。 对p73基因两面性的特点及研究进展作一综述。 最后结合重离子治疗肿瘤, 探讨了p73联合重离子治疗的新思路。 p73 was the first identified homologue of the tumor suppressor gene, p53. p73 has two groups of protein isoforms: TAp73 and DNp73. TAp73 can induce cell cycle arrest, resulting in the ability of apoptosis, however DNp73 has antagonistic property of a tumor promoting effect. In this paper, the dual roles of p73 gene and its research progress was reviewed. Finally, combined with heavy ion treatment of tumor, we explored some new ideas of p73 heavy ion joint therapy.     

lncRNA在癌细胞生长和代谢中的作用研究进展

从长链非编码RNA(long non-coding RNA, lncRNA)与癌细胞生长和代谢的关系角度, 系统地分析和综述了lncRNA如何通过促进或抑制细胞周期进程调节癌细胞生长, lncRNA如何通过调节上皮间质转化影响癌细胞迁移, 以及lncRNA在肿瘤细胞糖类和脂类代谢中如何发挥其作用.     

肿瘤细胞的原子力显微术成像及表征研究

本文简单介绍了原子力显微镜的发展史,以及原子力显微镜的工作原理、工作模式、活细胞在生理状态下的成像方式等,特别介绍了生物型原子力显微镜、高速原子力显微镜在生物学领域的研究及应用。原子力显微镜在扫描速度、扫描范围、扫描精度方面的不断改进将为肿瘤细胞学研究提供源源不断的动力。本文着重阐述了原子力显微术在肿瘤领域的研究进展,包括原子力显微镜在肿瘤细胞形貌学特性、硬度、粘弹性方面的研究现状,并对原子力显微镜在肿瘤诊断及抗肿瘤药物研发方面的应用前景进行了展望。     

妇科恶性肿瘤围手术期预防下肢深静脉血栓的治疗研究

目的探讨预防下肢深静脉血栓治疗对妇科恶性肿瘤患者的临床影响,为临床工作提供参考和依据。方法选取2014年5月—2015年9月间入住孝感市中心医院接受治疗的妇科恶性肿瘤患者70例,随机分成对照组和治疗组,每组35例。其中对照组患者给予常规治疗,治疗组患者给予预防下肢深静脉血栓治疗。对两组患者下肢深静脉血栓发生率以及患者、家属治疗满意率进行比较分析。结果经过治疗,治疗组仅有1例患者发生下肢深静脉血栓,经治疗康复出院,所有患者均未出现肺部栓塞;对照组患者共有13例发生下肢深静脉血栓,3例出现肺部栓塞,对照组患者下肢深静脉血栓发生率显著高于治疗组;同时治疗组患者及家属满意率显著高于对照组,以上差异均具有统计学意义(P0.05)。结论预防下肢深静脉血栓治疗可以显著降低妇科恶性肿瘤患者发病率,同时可以显著提高患者及家属的满意率,值得在临床工作中推广和应用。     

High‐Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis

Systemic delivery of therapeutic nucleic acids to target cells and tissues outside of the liver remains a major challenge. A biomimetic high‐density lipoprotein nanoparticle (HDL NP) is synthesized for delivery of a cholesteryl‐modified therapeutic nucleic acid to vascular endothelial cells (ECs), a cell type naturally targeted by HDL. HDL NPs adsorb cholesteryl‐modified oligonucleotides and protect them from nuclease degradation. As proof of principle, we deliver RNAi targeting vascular endothelial growth factor receptor 2 (VEGFR2) to ECs to effectively silence target mRNA and protein expression in vitro. In addition, data show that treatment strongly attenuates in vivo neovascularization measured using a standard angiogenesis assay and in hypervascular tumor allografts where a striking reduction in tumor growth is observed. For effective delivery, HDL NPs require the expression of the cell surface protein scavenger receptor type‐B1 (SR‐B1). No toxicity of HDL NPs is measured in vitro or after in vivo administration. Thus, by using a biomimetic approach to nucleic acid delivery, data demonstrate that systemically administered RNAi–HDL NPs target SR‐B1 expressing ECs to deliver functional anti‐angiogenic RNAi as a potential treatment of cancer and other neovascular diseases.     

OXIRIS project: Development of a new XRF device for the simultaneous detection and treatment of cancer

A novel and suitable energy-dispersive X-ray fluorescent (EDXRF) device, currently at the prototype stage, the Project OXIRIS (Orthovoltage X-Ray–Induced Radiation System), is presented for the simultaneous detection and treatment of cancer diseases. Monte Carlo simulation and experimental results of EDXRF signals from a small deep artificial tumor consisting of a solution of gold nanoparticles bio-targeted and immersed in a tissue-bioequivalent matrix are presented and compared. Briefly, the device consists of a dynamic orthovoltage X-ray fluence concentration coupled to confocal with an EDXRF system along with a sample holder for 3D scanning; all integrated and controlled by a dedicated software capable of controlling the whole operation functionalities: the X-ray source, the rotating arm, the sample holder, and the detection system. The software also includes dedicated subroutines for X-ray fluorescent spectra processing to correlate K-lines signal at each acquisition position with the corresponding high atomic number elements' concentration to produce a 3D distribution according to the user-defined grid. The confocal configuration ensures that the detected signal comes exclusively from the excited volume as defined by the bulk of the focal spot. Hence, the 3D image is achieved by scanning the sample holder through the movement of the sample-carrier stretcher moved by step motors in the 3 coordinated axes. The feasibility of the proposed methodology and the design of the prototype have been successfully demonstrated experimentally, targeting gold nanoparticles in water-equivalent phantoms.     

基于微流体装置的微血管网内红细胞流动和分布特性的研究简

实体肿瘤血管具有扩张、扭曲、不规则分支以及分支间连接絮乱等特征. 为了考察这些特征对血液流动的影响,将肿瘤血管简化为垂直相互贯通的微血管网,借助微流体实验装置,以一定浓度的红细胞悬液作为流动介质,研究红细胞在微血管网中的流动和分布特性. 具体实验方案如下：首先,采用软刻蚀技术,在聚二甲基硅氧烷（polydimethylsiloxane, PDMS）上加工出微血管网;然后,采用微注射泵控制微血管网入口处的红细胞悬液流量,使用倒置显微镜和高速摄影系统观察并记录实验过程;最后,通过Matlab 软件包Piv-lab 及高速摄影配套软件对获得的视频图像进行处理,提取红细胞在微血管网中的流动和分布数据. 数据处理结果显示,红细胞在微血管网中的流动和分布特性受悬液内的红细胞压积（hematocit, Hct）的影响. 红细胞随悬液Hct 的不同呈现2 种运动轨迹：一种为仅沿着轴向微管道流动;另一种是从轴向微管道流入并穿过径向微管道,再进入另一侧的轴向微管道. 另外,入口流量相同时,红细胞在微血管网中的流动速度随Hct 变化呈现不同,Hct 为3% 和5% 的红细胞速度要明显高于Hct 为1% 的红细胞速度.